CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test
Genetic testing plays a crucial role in the diagnosis and management of various genetic disorders. One such disorder is CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency. This rare genetic disorder is characterized by a deficiency of the enzyme aldosterone synthase, which is encoded by the CYP11B2 gene.
The CYP11B2 gene is responsible for the production of aldosterone, a hormone that regulates electrolyte balance and blood pressure. Individuals with CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency have low levels of aldosterone, leading to salt wasting and an inability to regulate sodium and potassium levels in the body. This can result in dehydration, low blood pressure, and electrolyte imbalances.
To diagnose CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency, a genetic test is required. The CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test is available at DNA Labs UAE. The test is priced at 4400.0 AED.
Test Details
The CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test utilizes NGS (Next-Generation Sequencing) technology. NGS genetic testing is a type of genetic testing that can analyze multiple genes simultaneously. In the case of CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency, NGS genetic testing can identify mutations or variants in the CYP11B2 gene that are responsible for the condition.
NGS genetic testing can help confirm a diagnosis, provide information about the specific genetic variant causing the disorder, and guide treatment decisions. It can also be used for carrier testing and prenatal testing in families with a known genetic mutation. Overall, NGS genetic testing plays a crucial role in the diagnosis and management of CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency, allowing for personalized and targeted treatment approaches.
Test Components and Price
The CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test is priced at 4400.0 AED. The test requires a sample condition of blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Test Department
The report for the CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test is typically delivered within 3 to 4 weeks. The test falls under the Genetics department at DNA Labs UAE.
Pre Test Information and Genetic Counselling
Before undergoing the CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counselling session may be conducted to draw a pedigree chart of family members affected with Hypoaldosteronism, congenital, due to CMO II deficiency.
By understanding the family history and conducting genetic counselling, healthcare professionals can better assess the risk and likelihood of genetic disorders within a family.
Conclusion
The CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test is a valuable tool in diagnosing and managing this rare genetic disorder. By utilizing NGS genetic testing, healthcare professionals can provide personalized and targeted treatment approaches for individuals affected by CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Contact us today to learn more about the CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO II Deficiency Genetic Test and how it can benefit you and your family.
Test Name | CYP11B2 Gene Hypoaldosteronism congenital due to CMO II deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CYP11B2 Gene Hypoaldosteronism, congenital, due to CMO II deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypoaldosteronism, congenital, due to CMO II deficiency |
Test Details |
CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency is a rare genetic disorder characterized by a deficiency of the enzyme aldosterone synthase, which is encoded by the CYP11B2 gene. This enzyme is responsible for the production of aldosterone, a hormone that regulates electrolyte balance and blood pressure. Individuals with this condition have low levels of aldosterone, leading to salt wasting and an inability to regulate sodium and potassium levels in the body. This can result in dehydration, low blood pressure, and electrolyte imbalances. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously. In the case of CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency, NGS genetic testing can identify mutations or variants in the CYP11B2 gene that are responsible for the condition. NGS genetic testing can help confirm a diagnosis, provide information about the specific genetic variant causing the disorder, and guide treatment decisions. It can also be used for carrier testing and prenatal testing in families with a known genetic mutation. Overall, NGS genetic testing plays a crucial role in the diagnosis and management of CYP11B2 gene hypoaldosteronism, congenital, due to CMO II deficiency, allowing for personalized and targeted treatment approaches. |